These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 16871462)

  • 41. Activities of 2-phthalimidethyl nitrate and 2-phthalimidethanol in the models of nociceptive response and edema induced by formaldehyde in mice and preliminary investigation of the underlying mechanisms.
    Godin AM; Araújo DP; César IC; Menezes RR; Brito AM; Melo IS; Coura GM; Bastos LF; Almeida MO; Byrro RM; Matsui TC; Batista CR; Pianetti GA; de Fátima Â; Machado RR; Coelho MM
    Eur J Pharmacol; 2015 Jun; 756():59-66. PubMed ID: 25794846
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of nociceptors by TRPV1-mediated entry of impermeant sodium channel blockers.
    Binshtok AM; Bean BP; Woolf CJ
    Nature; 2007 Oct; 449(7162):607-10. PubMed ID: 17914397
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Structure-affinity relationships and pharmacological characterization of new alkyl-resorcinol cannabinoid receptor ligands: Identification of a dual cannabinoid receptor/TRPA1 channel agonist.
    Brizzi A; Aiello F; Marini P; Cascio MG; Corelli F; Brizzi V; De Petrocellis L; Ligresti A; Luongo L; Lamponi S; Maione S; Pertwee RG; Di Marzo V
    Bioorg Med Chem; 2014 Sep; 22(17):4770-83. PubMed ID: 25065940
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Superbugs and superdrugs--SMi's 8th annual conference. A focus on antimicrobials. 24-25 April 2006, London, UK.
    Chan D
    IDrugs; 2006 Jul; 9(7):471-3. PubMed ID: 16821157
    [No Abstract]   [Full Text] [Related]  

  • 45. Design and characterization of a noncompetitive antagonist of the transient receptor potential vanilloid subunit 1 channel with in vivo analgesic and anti-inflammatory activity.
    García-Martínez C; Fernández-Carvajal A; Valenzuela B; Gomis A; Van Den Nest W; Ferroni S; Carreño C; Belmonte C; Ferrer-Montiel A
    J Pain; 2006 Oct; 7(10):735-46. PubMed ID: 17018334
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amelioration of neuropathic pain by novel transient receptor potential vanilloid 1 antagonist AS1928370 in rats without hyperthermic effect.
    Watabiki T; Kiso T; Kuramochi T; Yonezawa K; Tsuji N; Kohara A; Kakimoto S; Aoki T; Matsuoka N
    J Pharmacol Exp Ther; 2011 Mar; 336(3):743-50. PubMed ID: 21098091
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Piperazinyl carbamate fatty acid amide hydrolase inhibitors and transient receptor potential channel modulators as "dual-target" analgesics.
    Maione S; Costa B; Piscitelli F; Morera E; De Chiaro M; Comelli F; Boccella S; Guida F; Verde R; Ortar G; Di Marzo V
    Pharmacol Res; 2013 Oct; 76():98-105. PubMed ID: 23911581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transient receptor potential vanilloid 1 as a therapeutic target in analgesia.
    Szolcsányi J; Pintér E
    Expert Opin Ther Targets; 2013 Jun; 17(6):641-57. PubMed ID: 23421411
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Subtype-selective sodium channel blockers promise a new era of pain research.
    Priest BT; Kaczorowski GJ
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8205-6. PubMed ID: 17488822
    [No Abstract]   [Full Text] [Related]  

  • 50. Stem cells--SMi's inaugural conference. Drug discovery and therapeutics. 16-17 February 2009, London, UK.
    Kouremenou C
    IDrugs; 2009 Apr; 12(4):211-3. PubMed ID: 19350460
    [No Abstract]   [Full Text] [Related]  

  • 51. Toward better pain control.
    Basbaum AI; Julius D
    Sci Am; 2006 Jun; 294(6):60-7. PubMed ID: 16711361
    [No Abstract]   [Full Text] [Related]  

  • 52. Pharmacologic investigation of the mechanism underlying cold allodynia using a new cold plate procedure in rats with chronic constriction injuries.
    Tanimoto-Mori S; Nakazato-Imasato E; Toide K; Kita Y
    Behav Pharmacol; 2008 Feb; 19(1):85-90. PubMed ID: 18195599
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Stem Cells - SMi's second annual conference: achieving success in science and commercialisation.
    Lucifero D
    IDrugs; 2010 Apr; 13(4):232-4. PubMed ID: 20373250
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Protective effects of the flavonoid hesperidin methyl chalcone in inflammation and pain in mice: role of TRPV1, oxidative stress, cytokines and NF-κB.
    Pinho-Ribeiro FA; Hohmann MS; Borghi SM; Zarpelon AC; Guazelli CF; Manchope MF; Casagrande R; Verri WA
    Chem Biol Interact; 2015 Feb; 228():88-99. PubMed ID: 25617481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. 1-(2',4'-dichlorophenyl)-6-methyl-N-cyclohexylamine-1,4-dihydroindeno[1,2-c]pyrazole-3-carboxamide, a novel CB2 agonist, alleviates neuropathic pain through functional microglial changes in mice.
    Luongo L; Palazzo E; Tambaro S; Giordano C; Gatta L; Scafuro MA; Rossi FS; Lazzari P; Pani L; de Novellis V; Malcangio M; Maione S
    Neurobiol Dis; 2010 Jan; 37(1):177-85. PubMed ID: 19804829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. 3-Oxoisoindoline-1-carboxamides: potent, state-dependent blockers of voltage-gated sodium channel Na(V)1.7 with efficacy in rat pain models.
    Macsari I; Besidski Y; Csjernyik G; Nilsson LI; Sandberg L; Yngve U; Ahlin K; Bueters T; Eriksson AB; Lund PE; Venyike E; Oerther S; Hygge Blakeman K; Luo L; Arvidsson PI
    J Med Chem; 2012 Aug; 55(15):6866-80. PubMed ID: 22770500
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AM404 decreases Fos-immunoreactivity in the spinal cord in a model of inflammatory pain.
    Borsani E; Labanca M; Bianchi R; Rodella LF
    Brain Res; 2007 Jun; 1152():87-94. PubMed ID: 17459353
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Asthma & COPD - SMi's sixth annual conference.
    Shah S
    IDrugs; 2010 Jun; 13(6):376-8. PubMed ID: 20506058
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The effects of cannabinoid CB1, CB2 and vanilloid TRPV1 receptor antagonists on cocaine addictive behavior in rats.
    Adamczyk P; Miszkiel J; McCreary AC; Filip M; Papp M; Przegaliński E
    Brain Res; 2012 Mar; 1444():45-54. PubMed ID: 22325096
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Antisense and siRNA technologies--SMi's second annual conference. 16-17 February 2003, London, UK.
    Wright P
    IDrugs; 2004 Mar; 7(3):233-4. PubMed ID: 15017464
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.